FDA Approved: LEVETIRACETAM — Supplemental Application (Mylan Institutional LLC)

View source ↗

Summary

FDA granted a supplemental approval for LEVETIRACETAM (levetiracetam) by Mylan Institutional LLC under ANDA 203308. This action approves changes associated with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• LEVETIRACETAM (levetiracetam)

Snippet

SUPPL AP for LEVETIRACETAM (LEVETIRACETAM)